User profiles for Santiago Avila Rios

Santiago Avila-Rios

National Institute of Respiratory Diseases
Verified email at cieni.org.mx
Cited by 3209

[HTML][HTML] Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico

…, A Gazumyan, D Schaefer-Babajew, S Avila-Rios… - Cell, 2017 - cell.com
Antibodies to Zika virus (ZIKV) can be protective. To examine the antibody response in
individuals who develop high titers of anti-ZIKV antibodies, we screened cohorts in Brazil and …

[HTML][HTML] Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and …

…, AF Aghokeng, J Albert, R Avi, S Avila-Rios… - PLoS …, 2015 - journals.plos.org
Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug
resistance (TDR) are essential for informing first-line antiretroviral (ARV) therapy guidelines …

[HTML][HTML] HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and …

…, R Kugathasan, T Cutino, G Hunt, SA Rios… - The Lancet infectious …, 2018 - thelancet.com
Background Pretreatment drug resistance in people initiating or re-initiating antiretroviral
therapy (ART) containing non-nucleoside reverse transcriptase inhibitors (NNRTIs) might …

[HTML][HTML] Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

…, G Reyes-Teran, K Romero, S Avila-Rios… - The Lancet infectious …, 2016 - thelancet.com
Background Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through
wide-scale treatment as prevention and pre-exposure prophylaxis (PrEP). Potent tenofovir …

Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey

S Ávila-Ríos, C García-Morales, M Matías-Florentino… - The lancet HIV, 2016 - thelancet.com
Background WHO has developed a global HIV-drug resistance surveillance strategy,
including assessment of pretreatment HIV-drug resistance. We aimed to do a nationally …

[HTML][HTML] Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir

…, YA Luna-Villalobos, S Ávila-Ríos… - Nature …, 2023 - nature.com
Understanding the complexity of the long-lived HIV reservoir during antiretroviral therapy (ART)
remains a considerable impediment in research towards a cure for HIV. To address this, …

[HTML][HTML] Next-generation sequencing for HIV drug resistance testing: laboratory, clinical, and implementation considerations

S Ávila-Ríos, N Parkin, R Swanstrom, R Paredes… - Viruses, 2020 - mdpi.com
Higher accessibility and decreasing costs of next generation sequencing (NGS), availability
of commercial kits, and development of dedicated analysis pipelines, have allowed an …

The alpha variant (B. 1.1. 7) of SARS-CoV-2 failed to become dominant in Mexico

…, M Pérez-García, S Ávila-Ríos… - Microbiology …, 2022 - Am Soc Microbiol
During the coronavirus disease 2019 (COVID-19) pandemic, the emergence and rapid
increase of the B.1.1.7 (Alpha) lineage of severe acute respiratory syndrome coronavirus 2 (SARS…

Genomic analysis of early SARS-CoV-2 variants introduced in Mexico

…, I López-Martínez, S Ávila-Ríos… - Journal of …, 2020 - Am Soc Microbiol
The coronavirus disease 2019 (COVID-19) pandemic has affected most countries in the
world. Studying the evolution and transmission patterns in different countries is crucial to …

[HTML][HTML] Optic neuritis following SARS-CoV-2 infection

…, AK García-Morales, S Ávila-Ríos - Journal of …, 2021 - Springer
The most common neurologic symptoms in COVID-19 are headache, anosmia, and dysgeusia.
Optic neuritis is an unusual manifestation of SARS-CoV-2 infection. We report a case of a …